What Most GLP-1 Comparisons Leave Out: Four Programs, Four Criteria Worth Checking

Most side-by-side comparisons of GLP‑1 programs* focus on a single number, the monthly price. Starting there is the wrong move. Before you know whether $178 or $279 is a better deal, you need to know what you’re buying and from whom.

There are at least four questions worth asking before enrolling in any GLP‑1 program: Where does the medication come from? What does it cost over time? Who is overseeing your care? And what support is built into the price you pay? Running those four criteria across the programs people are comparing (Noom Med, Mochi Health, MEDVi, and the Eden GLP‑1 Weight Loss Program) reveals a picture that looks very different from the headline numbers.

GLP-1 Program Comparison at a Glance

† Pricing reflects compounded semaglutide injection plans at regular rates. Tirzepatide is available through most programs at higher monthly rates. Verify current pricing on each provider’s website before enrolling. Compounded medications are not FDA-approved and may be prescribed only when clinically appropriate.

Criterion 1: Pharmacy Sourcing Transparency

When a telehealth platform sends you a vial of compounded GLP‑1 therapy,* the company you signed up with didn’t make it. A compounding pharmacy did. Knowing which one, where it operates, and whether it’s been independently verified matters for the same reason you’d want to know who manufactured any medication you inject.

Noom Med states that third-party batch testing is performed on every batch and that it works with US-based pharmacy partners, but does not maintain a named pharmacy list with addresses on its product pages.

Mochi Health publicly names Aequita Pharmacy as a partner and has published batch-level Certificate of Analysis reports for Aequita medication on its site. What’s also worth noting is that as of early 2025, Washington state regulators issued a formal stop-service order against Aequita after inspections documented violations, including unqualified staff performing sterile compounding; a subsequent agreed order placed the pharmacy under ongoing compliance monitoring. Mochi has since expanded to a network of 33+ partner pharmacies but does not publish a complete named list with addresses for all of them.

MEDVi names Belmar Pharma Solutions as a pharmacy partner in its published materials and states that it meets regularly with pharmacies to review medication testing reports. It does not publish physical addresses for its pharmacy partners or provide accreditation details on its program pages.

Eden is currently the only program in this comparison that publicly names its pharmacy partners with physical addresses on its About page. Eden coordinates medication preparation and dispensing through its own pharmacy network and state-licensed 503A partner pharmacies, including GoGoMeds, which holds VIPPS accreditation through NABP (the National Association of Boards of Pharmacy). Eden also confirms third-party lot testing on its products. Few telehealth GLP‑1 programs publish sourcing information at that level of detail.

Criterion 2: Total Cost and Pricing Predictability

Headline prices rarely tell the whole story. Dose escalation is standard with GLP‑1 therapy, and the programs in this comparison handle that cost differently.

Noom Med starts at $149 for the first month of its full-dose GLP‑1Rx compounded semaglutide injection* program, then moves to $279/month, one of the higher ongoing costs in this comparison. The price includes access to Noom’s behavioral change platform, CBT‑based curriculum, and clinician messaging. Noom has expanded its lineup since launch and now offers several tiers, including lower-cost microdose options, and the $279/month rate does not appear to vary by dose level within the full-dose program.

Mochi Health has the lowest all-in monthly cost in this comparison at $178/month, structured as a $79/month membership (which covers physician and dietitian video visits), plus $99/month for compounded semaglutide injections.*

MEDVi starts at $179 for the first month, with refills at $299/month for compounded semaglutide injections*, the highest ongoing rate in this comparison. Medication, 1:1 physician guidance, and 24/7 support are included in that price. MEDVi does not charge a separate membership fee, and the $299/month rate holds regardless of dose level.

Eden starts at $149 for the first month, then $229/month ongoing with no membership fee*. Medication, consultation, support, and free expedited shipping with temperature‑controlled packaging are included. Eden offers the same price at every dose, meaning your monthly rate holds regardless of where you are in your titration schedule.

Criterion 3: Clinical Oversight and Provider Accountability

GLP‑1 therapies are prescription medications, and each program takes a different approach to provider transparency. Knowing who is making clinical decisions about your care, and how you can reach them, is a reasonable thing to ask before enrolling.

Noom Med publishes a named, credentialed medical leadership team on its transparency page, including a chief medical officer and pharmacy operations director. The individual clinicians who handle prescriptions are not named or profiled on the product pages. Ongoing access is message-based through the platform.

Mochi Health goes furthest on provider transparency. Patients can view and select their specific board‑certified physician and registered dietitian before starting, which no other program in this comparison offers. Care is delivered through mandatory video visits, and the provider roster is publicly viewable on the platform. Members also have 24/7 messaging access through the patient portal between visits.

MEDVi names two physicians on its homepage. Prescribing authority, however, is held by OpenLoop Health, an independent clinician network whose individual providers are not named on the platform. MEDVi discloses this arrangement in its own published terms. Ongoing support is message-based through a care coaching team of certified medical assistants and registered dietitians.

Eden publishes a named medical team on its About page, including Chief Medical Innovation Officer Dr. Halland Chen, VP of Pharmacy Operations Rebecca Emch, PharmD, and two Medical Advisory Board physicians. Like Noom, the individual clinicians in Eden’s partner physician network who handle prescriptions are not individually named in advance. Members have 24/7 message-based access to both their provider and a pharmacist.

Criterion 4: Support and Lifestyle Resources

Medication alone does not produce lasting results. Research published in JAMA Network Open in 2025 found that most patients with overweight or obesity discontinued GLP‑1 therapy within one year, with significantly higher rates among those without type 2 diabetes. What each program includes beyond the clinical visit matters.

Noom Med is the strongest in this category. Its CBT‑based behavioral platform, food logging tools, GLP‑1 Companion tools, and Muscle Defense™ workouts represent a genuinely robust lifestyle support system. Noom Circles, an in‑app community moderated by coaches, adds a peer accountability layer that no other program in this comparison offers natively.

Mochi Health and MEDVi do not offer structured lifestyle content outside of their clinical interactions. Support is delivered through provider and coaching team access, covered in Criterion 3.

Eden includes meal plans, workout guides, and weekly health guidance as part of its base program. It also offers a 2,000+ member Facebook community group for peer support.‡ Of the programs that offer lifestyle resources beyond clinical care, Eden and Noom are the only two in this comparison that do.

What This GLP-1 Program Comparison Reveals

Eden

Personalized GLP-1 Treatments

5 stars

SHOP NOW — $149.00

SHOP NOW — $149.00

No program in this comparison wins on every point. Mochi’s all-in price is the lowest in the group, and Noom’s behavioral platform is the most developed. Both are genuine strengths worth weighing against your own priorities.

However, across all four criteria, the Eden GLP‑1 Weight Loss Program is the only program that publicly names its pharmacy partners with addresses, holds VIPPS accreditation through GoGoMeds, confirms third-party lot testing, offers the same price at every dose, and includes 24/7 provider and pharmacist access in its base price. There are no membership fees, no cancellation fees, and no long-term contracts, making it a well-rounded and trustworthy choice.

If sourcing transparency and pricing predictability are the criteria that matter most to you, Eden is worth a closer look.

*All programs compared in this article offer access to GLP-1 therapies through licensed providers and state-licensed pharmacies. Compounded medications are not FDA-approved and may be prescribed only when clinically appropriate. Pricing, availability, and program details are subject to change; verify current information on each provider’s website before enrolling. This article is for informational purposes only and does not constitute medical advice. A licensed healthcare provider will determine if GLP-1 therapy is right for you.

‡Eden’s member community group had 2,000+ members at time of publication. Community membership is subject to change.

All competitor pricing in this article is sourced from official product pages as of the date of publication. Prices are subject to change. Verify current pricing at each provider’s website before enrolling. Semaglutide pricing shown; tirzepatide plans are available at higher rates through most programs.

This article is sponsored content published on GLP Insiders. It is written from an independent third-party perspective and does not constitute medical advice. Consult a licensed healthcare provider before starting any prescription therapy.

Writing Staff